RAPICIDE PA HIGH LEVEL DISINFECTANT
Report
- Report Number
- 2150060-2021-00025
- Event Type
- Injury
- Date Received
- October 30, 2021
- Date of Event
- October 1, 2021
- Report Date
- October 30, 2021
- Manufacturer
- MEDIVATORS INC
- Product Code
- FEB
- UDI-DI
- 00677964090172
- PMA / PMN Number
- K082988
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- OTHER
Narratives
IT IS UNKNOWN HOW THE DISINFECTANT CAME INTO CONTACT WITH THE EMPLOYEE'S SKIN. THE DURATION OF THE REPORTED SKIN REDNESS AND IRRITATION WAS NOT PROVIDED. FOLLOWING THE EVENT, THE USER CONTACTED CHEMTREC AND WAS PROVIDED THE RAPICIDE PA PART A SDS. THE EMPLOYEE SOUGHT MEDICAL ATTENTION AND A BANDAGE TO THE AFFECTED AREA WAS APPLIED. NO FURTHER MEDICAL INTERVENTION WAS REQUIRED. IT IS NOT KNOWN IF THE USER WAS WEARING PROPER PPE AT THE TIME OF THE REPORTED EVENT. THE RAPICIDE PA PART A SDS PROVIDES THE FOLLOWING WARNING LANGUAGE AND GUIDANCE, RELATED TO SKIN EXPOSURE AND PPE USAGE: "CAUSES SEVERE SKIN BURNS AND EYE DAMAGE. WASH HANDS THOROUGHLY AFTER HANDLING. WEAR PROTECTIVE GLOVES/PROTECTIVE CLOTHING/EYE PROTECTION/FACE PROTECTION...IF ON SKIN (OR HAIR): RINSE SKIN WITH WATER/SHOWER." NO ADDITIONAL REPORTS OF ADVERSE EVENT OR HARM WERE RECEIVED. MEDIVATORS WILL CONTINUE TO MONITOR FOR SIMILAR EVENTS TO ENSURE THE PRODUCT CONTINUES TO PERFORM AS EXPECTED.
A USER FACILITY REPORTED THAT RAPICIDE PA HIGH-LEVEL DISINFECTANT PART A SPLASHED ON AN EMPLOYEE'S FOREARM. THE EMPLOYEE EXPERIENCED REDNESS AND RAISING OF THE SKIN. THE EMPLOYEE WASHED THE AFFECTED AREA. THE EMPLOYEE WAS REPORTED TO BE WEARING GLOVES, BUT IT IS UNKNOWN IF OTHER PERSONAL PROTECTIVE EQUIPMENT (PPE) WAS WORN AT THE TIME OF THE EXPOSURE. NO ADDITIONAL REPORTS OF INJURY WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1623228 | RAPICIDE PA HIGH LEVEL DISINFECTANT | HIGH LEVEL DISINFECTANT | FEB | MEDIVATORS INC | ML02-0117 | 00677964090172 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |